Table 2. Outcome measures.
| Experimental group (n=6) | Control group (n=6) | |||||
|---|---|---|---|---|---|---|
| Pretest | Posttest | Follow-up | Pretest | Posttest | Follow-up | |
| FVC (l) | 2.7 ± 0.3a | 3.2 ± 0.3*+ | 3.2 ± 0.2+ | 2.3 ± 0.2 | 2.8 ± 0.2* | 2.9 ± 0.2 |
| FEV1 (l) | 1.9 ± 0.2 | 2.4 ± 0.2*+ | 2.4 ± 0.2+ | 1.9 ± 0.2 | 2.0 ± 0.2 | 2.1 ± 0.2 |
| SpO2 (%) | 95.8 ± 0.9 | 96.4 ± 0.8 | 96.9 ± 0.7 | 95.8 ± 0.6 | 96.4 ± 0.7 | 96.9 ± 0.7 |
| 10MWT (sec) | 14.5 ± 1.3 | 10.2 ± 0.7* | 10.4 ± 0.9 | 14.9 ± 2.2 | 11.4 ± 0.9* | 11.5 ± 1.1 |
| 6MWT (m) | 251.3 ± 52.6 | 318.0 ± 41.2*+ | 318.0 ± 33.1+ | 229.5 ± 46.9 | 259.0 ± 47.4* | 265.2 ± 46.1 |
aMeans ± SD
*Significant difference within group. +Significant difference between groups. FVC: forced vital capacity; FEV1: forced expiratory volume in one second; SpO2: saturation pulse oximetry oxygen; 10MWT: 10-meter walking test; 6MWT: six-minute walking test. The pretest was performed before the intervention, and the posttest was performed after four weeks. The significance of differences was accepted for values of p<0.05.